These results further confirmed that AGAP2-AS1 participates in the development of CCA through its effect on the proliferation of CCA cells; inhibition of AGAP2-AS1 expression leads to a decrease in the growth of CCA cells. The gene discussed is AGAP2; the disease is cholangiocarcinoma.